A clinical trial examining the feasibility of SingINg For breathing in COPD aNd ILD pAtients

St Vincents Hospital Melbourne0 个研究点目标入组 35 人开始时间: 2021年9月20日最近更新: 2022年8月29日

适应症

试验速览

暂无简介。

•Patient Cohort:
•1.Participants with a confirmed diagnosis of COPD or ILD
•Diagnosis confirmed on either CT chest scan (within the last 5 years) or lung function testing (within the last 2 years)
•2.On stable treatment for at least 4 weeks
•Has not started any new or changed existing cardiorespiratory medications (including antibiotics and oral steroids). To be determined by study site clinician.
•Has not been admitted to hospital with an exacerbations of their underlying disease (COPD or ILD) within the past 4 weeks.
•3.Modified Medical Research Council dyspnoea score grerater than or equal to 2
•4.Aged 18 years or over
•5.Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
•Carers Cohort (optional):
•1.Nominated carers of eligible patients will be eligible to participate.
•2.Aged 18 years or over
•3.Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.

•1.Participants cannot be actively undertaking a centre-based pulmonary rehabilitation program. However past completion of such a program is permitted.

发起方

St Vincents Hospital Melbourne